Compare Vaxcyte Inc. Common Stock (PCVX) vs UDR Inc. Common Stock (UDR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Vaxcyte Inc. Common Stock vs UDR Inc. Common Stock — how do they compare? Vaxcyte Inc. Common Stock trades at $67.27 (market cap $10.51B), while UDR Inc. Common Stock trades at $33.9 (market cap $10.93B). The key difference: Vaxcyte Inc. Common Stock and UDR Inc. Common Stock are close in size by market cap, and UDR Inc. Common Stock pays a 5.12% dividend while Vaxcyte Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Vaxcyte Inc. Common Stock for 0 Days and UDR Inc. Common Stock for 0 Days on average.
| PCVX | UDR | |
|---|---|---|
Market Cap | $10.51B | $10.93B |
Volume | 2,644,694 | 2,607,837 |
Sector | Health | Real Estate |
52-Week High | $73.82 | $41.24 |
52-Week Low | $40.32 | $33.27 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $9.14B | $16.96B |
Dividend Yield | — | 5.12% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Vaxcyte Inc. Common Stock
Vaxcyte, Inc. is a clinical-stage vaccine company that engineers protein-based vaccines to prevent bacterial diseases such as invasive pneumococcal disease, using its proprietary cell-free protein synthesis platform to develop candidates including the pneumococcal conjugate vaccines VAX-31 and VAX-24.
Read more on PCVX →About UDR Inc. Common Stock
UDR, Inc. is a self-administered real estate investment trust that owns, operates, develops, and redevelops multifamily apartment communities across targeted US markets. The company generates income primarily through leasing apartment homes, with a portfolio concentrated in coastal and Sunbelt metropolitan areas.
Read more on UDR →
